N E M Jaspers

Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people

N E M Jaspers, Michael J. Blaha, Kunihiro Matsushita et al. · European Heart Journal · 2019 · 115 citations · Full text

Observational study of the medical management of patients with peripheral artery disease

Athanasios Saratzis, N E M Jaspers, Brenig Llwyd Gwilym et al. · British journal of surgery · 2019 · 87 citations · Full text

Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives

N E M Jaspers, Frank L.J. Visseren, Mattijs E. Numans et al. · BMJ Open · 2018 · 16 citations · Full text

SPRINT trial: It’s not just the blood pressure!

Gijs F. N. Berkelmans, Frank L.J. Visseren, N E M Jaspers et al. · European Journal of Preventive Cardiology · 2017 · 11 citations · Full text

Hypertension, Heart Failure, Cardiovascular Pharmacology +19

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial

N E M Jaspers, Frank L.J. Visseren, Yolanda van der Graaf et al. · BMJ Open · 2021 · 11 citations · Full text